Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer

NCT01784978 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitment

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Sunitinib
DRUG: Everolimus

Sponsor

Associació per a la Recerca Oncologica, Spain

Collaborators

[object Object]
[object Object]